Literature DB >> 6785751

A human neutrophil-dependent pathway for generation of angiotensin II: purification and physicochemical characterization of the plasma protein substrate.

B U Wintroub, L B Klickstein, C E Kaempfer, K F Austen.   

Abstract

Human neutrophils contain a neutral protease, previously designated "neutral peptide-generating protease," which generates a smooth muscle contractile activity from a plasma protein substrate. The plasma protein substrate has been purified to homogeneity from fresh citrated human plasma by 45% (wt/vol) ammonium sulfate precipitation of contaminating proteins, Affi-Gel Blue affinity chromatography, hydroxylapatite chromatography, phenyl-Sepharose hydrophobic chromatography, and Sephacryl S-200 gel filtration. The purified product produced a single stained protein on alkaline disc gel electrophoresis and elicited a monospecific goat antiserum. Purification was approximately 330- to 350-fold, and overall recovery was 6-11% of substrate protein in starting plasma as determined by quantitative radial immunodiffusion assay. The substrate has an isoelectric point of pH 4.6-5.1 and is a single polypeptide chain glycoprotein of Mr 62,000-67,000 by sodium dodecyl sulfate electrophoresis. The mean(+/- SD) concentration of this plasma protein substrate in normal serum is 120 +/- 22 microgram/ml. The plasma protein substrate of the neutrophil neutral protease may be identical to human angiotensinogen (renin substrate) because the physicochemical characteristics are similar and the peptide product is recognized by antibody to angiotensin II.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6785751      PMCID: PMC319976          DOI: 10.1073/pnas.78.2.1204

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  PROLONGED INFUSIONS OF ANGIOTENSIN II AND NOREPINEPHRINE AND BLOOD PRESSURE, ELECTROLYTE BALANCE, AND ALDOSTERONE AND CORTISOL SECRETION IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.

Authors:  R P AMES; A J BORKOWSKI; A M SICINSKI; J H LARAGH
Journal:  J Clin Invest       Date:  1965-07       Impact factor: 14.808

3.  THE EFFECTS OF INTRAVENOUS INFUSIONS OF VALINE-5 ANGIOTENSIN II AND OTHER PRESSOR AGENTS ON URINARY ELECTROLYTES AND CORTICOSTEROIDS, INCLUDING ALDOSTERONE.

Authors:  P Biron; E Koiw; W Nowaczynski; J Brouillet; J Genest
Journal:  J Clin Invest       Date:  1961-02       Impact factor: 14.808

Review 4.  Renin-angiotensin system: biochemistry and mechanisms of action.

Authors:  M J Peach
Journal:  Physiol Rev       Date:  1977-04       Impact factor: 37.312

5.  Comparative effects of angiotensin and noradrenaline on resistance, capacitance, and precapillary sphincter vessels in cat skeletal muscle.

Authors:  J Järhult
Journal:  Acta Physiol Scand       Date:  1971-03

6.  Effects of angiotensin II and some analogues on vascular permeability in the rabbit.

Authors:  A L Robertson; P A Khairallah
Journal:  Circ Res       Date:  1972-12       Impact factor: 17.367

7.  Comparison of haemodynamic effects of equipressor doses of intravenous angiotensin and noradrenaline in man.

Authors:  J Brod; Z Hejl; A Hornych; J Jirka; V Slechta; B Buriánová
Journal:  Clin Sci       Date:  1969-04       Impact factor: 6.124

Review 8.  Biochemistry and kinetics of the renin-angiotensin system.

Authors:  L T Skeggs; K E Lentz; A B Gould; H Hochstrasser; J R Kahn
Journal:  Fed Proc       Date:  1967 Jan-Feb

9.  the preparation of human kininogen. II. Further characterization of purified human kininogen.

Authors:  J Spragg; K F Austen
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

10.  Human angiotensinogen. Purification partial characterization, and a comparison with animal prohormones.

Authors:  M P Printz; J M Printz; R T Dworschack
Journal:  J Biol Chem       Date:  1977-03-10       Impact factor: 5.157

View more
  6 in total

Review 1.  Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate.

Authors:  Sarfaraz Ahmad; Jasmina Varagic; Leanne Groban; Louis J Dell'Italia; Sayaka Nagata; Neal D Kon; Carlos M Ferrario
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

2.  Confirmation of direct angiotensin formation by kallikrein.

Authors:  H Maruta; K Arakawa
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

3.  Human mast cell carboxypeptidase. Purification and characterization.

Authors:  S M Goldstein; C E Kaempfer; J T Kealey; B U Wintroub
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

4.  Bacillus Calmette-Guérin-stimulated neutrophils release chemotaxins for monocytes in rabbit pleural spaces and in vitro.

Authors:  V B Antony; S A Sahn; A C Antony; J E Repine
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

5.  Identification of a human neutrophil angiotension II-generating protease as cathepsin G.

Authors:  M G Tonnesen; M S Klempner; K F Austen; B U Wintroub
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

6.  A human neutrophil-dependent pathway for generation of angiotensin II. Purification of the product and identification as angiotensin II.

Authors:  B U Wintroub; L B Klickstein; K W Watt
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.